BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24361957)

  • 1. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided protein data analysis.
    Hasan MA; Khan MA; Sharmin T; Hasan Mazumder MH; Chowdhury AS
    Gene; 2016 Jan; 575(1):132-43. PubMed ID: 26319513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential drug targets by subtractive genome analysis of Bacillus anthracis A0248: An in silico approach.
    Rahman A; Noore S; Hasan A; Ullah R; Rahman H; Hossain A; Ali Y; Islam S
    Comput Biol Chem; 2014 Oct; 52():66-72. PubMed ID: 25254941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant Staphylococcus aureus.
    Zoraghi R; See RH; Gong H; Lian T; Swayze R; Finlay BB; Brunham RC; McMaster WR; Reiner NE
    Biochemistry; 2010 Sep; 49(35):7733-47. PubMed ID: 20707314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets.
    Butt AM; Tahir S; Nasrullah I; Idrees M; Lu J; Tong Y
    Infect Genet Evol; 2012 Jan; 12(1):53-62. PubMed ID: 22057004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative drug and vaccine target protein identification using comparative genomic analysis of KEGG annotated metabolic pathways of Mycoplasma hyopneumoniae.
    Damte D; Suh JW; Lee SJ; Yohannes SB; Hossain MA; Park SC
    Genomics; 2013 Jul; 102(1):47-56. PubMed ID: 23628646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomics study for the identification of drug and vaccine targets in Staphylococcus aureus: MurA ligase enzyme as a proposed candidate.
    Ghosh S; Prava J; Samal HB; Suar M; Mahapatra RK
    J Microbiol Methods; 2014 Jun; 101():1-8. PubMed ID: 24685600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug target.
    Zoraghi R; See RH; Axerio-Cilies P; Kumar NS; Gong H; Moreau A; Hsing M; Kaur S; Swayze RD; Worrall L; Amandoron E; Lian T; Jackson L; Jiang J; Thorson L; Labriere C; Foster L; Brunham RC; McMaster WR; Finlay BB; Strynadka NC; Cherkasov A; Young RN; Reiner NE
    Antimicrob Agents Chemother; 2011 May; 55(5):2042-53. PubMed ID: 21357306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond conventional antibiotics for the future treatment of methicillin-resistant Staphylococcus aureus infections: two novel alternatives.
    Fitzgerald-Hughes D; Devocelle M; Humphreys H
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):399-412. PubMed ID: 22409572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome of a methicillin-resistant Staphylococcus aureus clinical strain of sequence type ST398.
    Monteiro R; Vitorino R; Domingues P; Radhouani H; Carvalho C; Poeta P; Torres C; Igrejas G
    J Proteomics; 2012 Jun; 75(10):2892-915. PubMed ID: 22245554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
    Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
    Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational subtractive genome analysis for the characterization of novel drug targets in Klebsiella pneumonia strain PittNDM01.
    Rafiq H; Ullah K; Ahmad B; Rehman AU; Shah MK; Khan A; Uddin R; Azam SS; Wadood A
    Microb Pathog; 2020 Sep; 146():104245. PubMed ID: 32423883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence factors and genetic characteristics of methicillin-resistant and -susceptible Staphylococcus aureus isolates in Myanmar.
    Aung MS; Urushibara N; Kawaguchiya M; Aung TS; Mya S; San T; Nwe KM; Kobayashi N
    Microb Drug Resist; 2011 Dec; 17(4):525-35. PubMed ID: 21834665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential genome analyses of metabolic enzymes in Pseudomonas aeruginosa for drug target identification.
    Perumal D; Lim CS; Sakharkar KR; Sakharkar MK
    In Silico Biol; 2007; 7(4-5):453-65. PubMed ID: 18391237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation between expression level of femB and resistance phenotype of methicillin-resistant Staphylococcus aureus (MRSA)].
    Liu ZZ; Xiong YL; Fan XJ; Gao YY; Yu RJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):661-5. PubMed ID: 22007494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-infective drug development for MRSA.
    Daniel A
    Methods Mol Biol; 2014; 1085():311-31. PubMed ID: 24085703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase.
    Axerio-Cilies P; See RH; Zoraghi R; Worral L; Lian T; Stoynov N; Jiang J; Kaur S; Jackson L; Gong H; Swayze R; Amandoron E; Kumar NS; Moreau A; Hsing M; Strynadka NC; McMaster WR; Finlay BB; Foster LJ; Young RN; Reiner NE; Cherkasov A
    ACS Chem Biol; 2012 Feb; 7(2):350-9. PubMed ID: 22066782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.